Adage Capital Partners GP L.L.C. Boosts Stock Position in HealthEquity, Inc. $HQY

Adage Capital Partners GP L.L.C. lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 50.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,000 shares of the company's stock after buying an additional 4,000 shares during the period. Adage Capital Partners GP L.L.C.'s holdings in HealthEquity were worth $1,060,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. EP Wealth Advisors LLC boosted its position in shares of HealthEquity by 17.9% during the first quarter. EP Wealth Advisors LLC now owns 5,372 shares of the company's stock valued at $475,000 after buying an additional 817 shares during the last quarter. Ashford Capital Management Inc. lifted its holdings in HealthEquity by 2.1% during the first quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company's stock worth $24,302,000 after acquiring an additional 5,687 shares during the period. Baird Financial Group Inc. bought a new stake in HealthEquity during the first quarter worth $848,000. Clough Capital Partners L P lifted its holdings in HealthEquity by 133.9% during the first quarter. Clough Capital Partners L P now owns 87,000 shares of the company's stock worth $7,688,000 after acquiring an additional 49,800 shares during the period. Finally, WPG Advisers LLC bought a new stake in HealthEquity during the first quarter worth $28,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Buying and Selling

In other news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.50% of the stock is currently owned by insiders.

HealthEquity Price Performance

HealthEquity stock traded down $1.48 during midday trading on Wednesday, hitting $91.51. 790,954 shares of the company's stock were exchanged, compared to its average volume of 1,242,943. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The stock has a 50-day moving average price of $93.74 and a two-hundred day moving average price of $94.72. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The company has a market cap of $7.88 billion, a P/E ratio of 55.46, a PEG ratio of 1.33 and a beta of 0.50.

Wall Street Analyst Weigh In

HQY has been the topic of a number of recent analyst reports. The Goldman Sachs Group lifted their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. JPMorgan Chase & Co. lifted their price target on HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a report on Wednesday, September 3rd. Royal Bank Of Canada lifted their price target on HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, September 3rd. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 price target (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, JMP Securities lifted their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $119.77.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.